Pharma-Bio Serv (OTCMKTS:PBSV) Releases Quarterly Earnings Results, Beats Estimates By $1.41 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) released its quarterly earnings results on Tuesday. The company reported $1.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $1.41, reports. The business had revenue of $2.30 million during the quarter, compared to analysts’ expectations of $2.70 million. Pharma-Bio Serv had a negative return on equity of 0.83% and a negative net margin of 1.11%.

Pharma-Bio Serv Stock Performance

Shares of PBSV opened at $0.48 on Wednesday. The company’s 50-day moving average price is $0.54 and its 200 day moving average price is $0.57. Pharma-Bio Serv has a 12-month low of $0.35 and a 12-month high of $1.36. The firm has a market cap of $10.99 million, a P/E ratio of -48.00 and a beta of 0.68.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.